Latest Dexcom Inc (DXCM) Headlines Upcoming Con
Post# of 84
Posted On: 03/13/2014 7:48:37 AM
Latest Dexcom Inc (DXCM) Headlines
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ
XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Dexcom Supports NASCAR Driver Ryan Reed's American Diabetes Association Drive to Stop Diabetes(SM) Initiative
Business Wire - Wed Mar 05, 3:04PM CST
Dexcom, Inc., (NASDAQ XCM), the leader in continuous glucose monitoring (CGM), announced today it is supporting NASCAR driver Ryan Reed and the American Diabetes Association's Drive to Stop Diabetes(SM) national diabetes awareness initiative. As part of the campaign, Dexcom will support Ryan Reed and the Association's Drive to Stop Diabetes presented by Lilly Diabetes to build awareness about the importance of daily monitoring and tracking of glucose trends in the management of diabetes.
Is DexCom (DXCM) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:48AM CST
DexCom can be a promising growth stock in the Medical Instruments industry space backed by significant rise in estimates and strong potential for outperformance
Insider Trading Alert - WAB, DXCM And CMCSA Traded By Insiders
at The Street - Fri Feb 28, 10:45AM CST
Stocks with insider trader activity include WAB, DXCM and CMCSA
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
DexCom Announces Upcoming Conference Presentations
Business Wire - Tue Feb 25, 7:30AM CST
DexCom, Inc. (NASDAQ XCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:
U.S. Bancorp Asset Management, Inc. Announces March Distributions for Closed-End Funds
Business Wire - Fri Feb 21, 11:15AM CST
The closed-end funds listed below, which are advised by U.S. Bancorp Asset Management, Inc. (NYSE:USB), today declared their March distributions. The distributions will be allocated on a per-share basis on the common stock. The distributions have an ex-dividend date of March 3, 2014 and will be paid on March 19, 2014 to shareholders of record on March 5, 2014.
DexCom, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Thu Feb 20, 3:01PM CST
DexCom, Inc. (Nasdaq: DXCM) today reported its audited financial results as of and for the quarter and fiscal year ended December 31, 2013.
Can the Rally in DexCom (DXCM) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 7:57AM CST
Can the Rally in DexCom (DXCM) Shares Continue?
Teleflex Recalls Tracheal Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 1:50PM CST
Teleflex Medical has announced a worldwide voluntary recall of its ISIS HVT Tracheal Tube.
Cepheid Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 2:20PM CST
On Feb 4, Zacks Investment Research downgraded Cepheid to a Zacks Rank #5 (Strong Sell).
The Zacks Analyst Blog Highlights:Henry Schein, Cyberonics, DexCom, Regeneron Pharmaceuticals and Bayer
PR Newswire - Tue Feb 11, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Henry Schein Inc. (Nasdaq:HSIC-Free Report), Cyberonics Inc. (Nasdaq:CYBX-Free Report), DexCom, Inc. (Nasdaq XCM-Free Report), Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN-Free Report) and Bayer (OTC:BAYRY-Free Report).
Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 11:41AM CST
This hike is expected to result in 385 million new grant opportunities for researchers.
Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:30AM CST
The shares of Fluidigm Corporation fell over 6% on the day.This reverses the most recent uptrend for the company, as the stock is now up almost 8% since Jan 29.This scientific instruments company has seen a flat track record when it comes to current year estimate revisions.
FDA Approval for DexCom's G4 PLATINUM - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 4:10PM CST
DexCom G4 PLATINUM gets FDA approval for use in children affected with diabetes aged between 2 and 17 years.
DexCom Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for February 20, 2014 at 4:30 p.m. Eastern Time
Business Wire - Thu Feb 06, 7:30AM CST
DexCom, Inc. (NASDAQ XCM) today announced that it plans to release its fourth quarter and full year 2013 financial results after market close on Thursday, February 20, 2014. Management will hold a conference call to review the company's fourth quarter and full year 2013 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "About," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference.
DexCom to Present at Leerink Global Healthcare Conference 2014
Business Wire - Thu Feb 06, 7:30AM CST
DexCom, Inc. (NASDAQ XCM) today announced that Steve Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Leerink Global Healthcare Conference 2014 in New York, New York on Thursday, February 13, 2014 at 1:25pm (EST). The presentation, which will occur live at The Waldorf Astoria, will be concurrently webcast.
DXCM: Improving the Quality of Life for Children With Diabetes
at The Street - Wed Feb 05, 7:38PM CST
A major FDA approval for Dexcom's continuous glucose monitor (CGM) device for children with diabetes was announced a couple of days ago, and this is one such event that will revolutionize the industry and improve the quality of life affecting so many...
'Mad Money' Lightning Round: Staying Away From Valero Energy
at The Street - Wed Feb 05, 5:00AM CST
Cramer's no fan of Activision Blizzard but he does like Zoetis.
Jim Cramer's 'Mad Money' Recap: What's a Stock Gotta Do to Get Some Love?
at The Street - Tue Feb 04, 7:17PM CST
For a stock to rally it must beat on the top line, the bottom line and raise guidance to impress Wall Street -- and even then its not guaranteed, Cramer complains.
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register Dexcom Supports NASCAR Driver Ryan Reed's American Diabetes Association Drive to Stop Diabetes(SM) Initiative
Business Wire - Wed Mar 05, 3:04PM CST
Dexcom, Inc., (NASDAQ
XCM), the leader in continuous glucose monitoring (CGM), announced today it is supporting NASCAR driver Ryan Reed and the American Diabetes Association's Drive to Stop Diabetes(SM) national diabetes awareness initiative. As part of the campaign, Dexcom will support Ryan Reed and the Association's Drive to Stop Diabetes presented by Lilly Diabetes to build awareness about the importance of daily monitoring and tracking of glucose trends in the management of diabetes. Is DexCom (DXCM) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:48AM CST
DexCom can be a promising growth stock in the Medical Instruments industry space backed by significant rise in estimates and strong potential for outperformance
Insider Trading Alert - WAB, DXCM And CMCSA Traded By Insiders
at The Street - Fri Feb 28, 10:45AM CST
Stocks with insider trader activity include WAB, DXCM and CMCSA
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
DexCom Announces Upcoming Conference Presentations
Business Wire - Tue Feb 25, 7:30AM CST
DexCom, Inc. (NASDAQ
XCM) today announced that management will present an update on DexCom at the following upcoming investor conferences: U.S. Bancorp Asset Management, Inc. Announces March Distributions for Closed-End Funds
Business Wire - Fri Feb 21, 11:15AM CST
The closed-end funds listed below, which are advised by U.S. Bancorp Asset Management, Inc. (NYSE:USB), today declared their March distributions. The distributions will be allocated on a per-share basis on the common stock. The distributions have an ex-dividend date of March 3, 2014 and will be paid on March 19, 2014 to shareholders of record on March 5, 2014.
DexCom, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results
Business Wire - Thu Feb 20, 3:01PM CST
DexCom, Inc. (Nasdaq: DXCM) today reported its audited financial results as of and for the quarter and fiscal year ended December 31, 2013.
Can the Rally in DexCom (DXCM) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 7:57AM CST
Can the Rally in DexCom (DXCM) Shares Continue?
Teleflex Recalls Tracheal Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 1:50PM CST
Teleflex Medical has announced a worldwide voluntary recall of its ISIS HVT Tracheal Tube.
Cepheid Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 2:20PM CST
On Feb 4, Zacks Investment Research downgraded Cepheid to a Zacks Rank #5 (Strong Sell).
The Zacks Analyst Blog Highlights:Henry Schein, Cyberonics, DexCom, Regeneron Pharmaceuticals and Bayer
PR Newswire - Tue Feb 11, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Henry Schein Inc. (Nasdaq:HSIC-Free Report), Cyberonics Inc. (Nasdaq:CYBX-Free Report), DexCom, Inc. (Nasdaq
XCM-Free Report), Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN-Free Report) and Bayer (OTC:BAYRY-Free Report). Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 11:41AM CST
This hike is expected to result in 385 million new grant opportunities for researchers.
Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:30AM CST
The shares of Fluidigm Corporation fell over 6% on the day.This reverses the most recent uptrend for the company, as the stock is now up almost 8% since Jan 29.This scientific instruments company has seen a flat track record when it comes to current year estimate revisions.
FDA Approval for DexCom's G4 PLATINUM - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 4:10PM CST
DexCom G4 PLATINUM gets FDA approval for use in children affected with diabetes aged between 2 and 17 years.
DexCom Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for February 20, 2014 at 4:30 p.m. Eastern Time
Business Wire - Thu Feb 06, 7:30AM CST
DexCom, Inc. (NASDAQ
XCM) today announced that it plans to release its fourth quarter and full year 2013 financial results after market close on Thursday, February 20, 2014. Management will hold a conference call to review the company's fourth quarter and full year 2013 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "About," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference. DexCom to Present at Leerink Global Healthcare Conference 2014
Business Wire - Thu Feb 06, 7:30AM CST
DexCom, Inc. (NASDAQ
XCM) today announced that Steve Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Leerink Global Healthcare Conference 2014 in New York, New York on Thursday, February 13, 2014 at 1:25pm (EST). The presentation, which will occur live at The Waldorf Astoria, will be concurrently webcast. DXCM: Improving the Quality of Life for Children With Diabetes
at The Street - Wed Feb 05, 7:38PM CST
A major FDA approval for Dexcom's continuous glucose monitor (CGM) device for children with diabetes was announced a couple of days ago, and this is one such event that will revolutionize the industry and improve the quality of life affecting so many...
'Mad Money' Lightning Round: Staying Away From Valero Energy
at The Street - Wed Feb 05, 5:00AM CST
Cramer's no fan of Activision Blizzard but he does like Zoetis.
Jim Cramer's 'Mad Money' Recap: What's a Stock Gotta Do to Get Some Love?
at The Street - Tue Feb 04, 7:17PM CST
For a stock to rally it must beat on the top line, the bottom line and raise guidance to impress Wall Street -- and even then its not guaranteed, Cramer complains.
(0)
(0)DexCom Inc. (DXCM) Stock Research Links
Scroll down for more posts ▼